MiR-210: An important player in the pathogenesis of preeclampsia?

Journal of Cellular and Molecular Medicine

Volumn 16, Issue 4, 2012, Pages 943-944

  Liu, Changjiang ^a   Zhou, Yaojun ^a   Zhang, Zhigao ^a  

^a GENERAL HOSPITAL OF NORTHERN THEATER COMMAND   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA;

FEMALE; HUMAN; METABOLISM; NOTE; PREECLAMPSIA; PREGNANCY; TROPHOBLAST;

FEMALE; HUMANS; MICRORNAS; PRE-ECLAMPSIA; PREGNANCY; TROPHOBLASTS;

EID: 84867870028     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2011.01370.x     Document Type: Note

References (8)

1. Loscalzo J. The cellular response to hypoxia: tuning the system with microRNAs. J Clin Invest. 2010; 120: 3815-7.
2. Zhang Y, Fei M, Xue G, et al. Elevated levels of hypoxia-inducible microRNA-210 in preeclampsia: new insights into molecular mechanisms for the disease. J Cell Mol Med.; doi: 10.1111/j.1582-4934.2011.01290.x.
3. Huang X, Le QT, Giaccia AJ. MiR-210-micromanager of the hypoxia pathway. Trends Mol Med. 2010; 16: 230-7.
4. Li T, Cao H, Zhuang J, et al. Identification of miR-130a, miR-27b and miR-210 as serum biomarkers for atherosclerosis obliterans. Clin Chim Acta. 2011; 412: 66-70.
5. Fasanaro P, D'Alessandra Y, Di Stefano V, et al. MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3. J Biol Chem. 2008; 283: 15878-83.
6. Ivan M, Harris AL, Martelli F, et al. Hypoxia response and microRNAs: no longer two separate worlds. J Cell Mol Med. 2008; 12: 1426-31.
7. Ghosh S, Hayden MS. New regulators of NF-kappaB in inflammation. Nat Rev Immunol. 2008; 8: 837-48.
8. Puissegur MP, Mazure NM, Bertero T, et al. miR-210 is overexpressed in late stages of lung cancer and mediates mitochondrial alterations associated with modulation of HIF-1 activity. Cell Death Differ. 2010; 18: 465-78.